Where to buy filgotinib

Filgotinib, sold under the trade nameJyseleca, is a drug used to treat rheumatoid arthritis (RA) and ulcerative colitis (UC) and is manufactured by the Belgian-Dutch biotech company Galapagos NV (Belgian-Dutch biotech company Galapagos NV) developed. Figotinib is a class of drugs calledJAK inhibitors. These drugs work by limiting the action ofJanus kinase, which is involved in the inflammation that causes symptoms of rheumatoid arthritis and some other diseases.

Figotinib is not a pain reliever, but it can reduce symptoms and limit joint damage that may be caused by a patient's condition. If filgotinib is effective for a patient, symptoms should begin to improve within the first 12 weeks after starting the drug, and may be sooner, but it is possible not to notice the full benefit of the first months of treatment. In addition to targeting Janus kinase (JAK) 1 inhibition, filgotinib also targets pro-inflammatory cytokine signaling by inhibiting IL-6-induced STAT1 phosphorylation. Serum C-reactive protein levels are also reduced by filgotinib administration.

The original drug of filgotinib has not yet been launched in China, so it is not included in medical insurance. Domestic patients cannot yet purchase this drug. The Bangladeshi version of the filgotinitine generic drug currently on the market overseas, specifications100mg*30 tablets may cost more than 500 yuan per box (the price may fluctuate due to exchange rates), and its drug ingredients are basically the same as those of the original drug. For more drug information and specific prices, please consult Yaode Medical Consultant.